Skip to main content

International Journal of Clinical Oncology

Ausgabe 2/2017

Inhalt (19 Artikel)

Invited Review Article

Biomarkers for precision medicine in bladder cancer

Takahiro Kojima, Koji Kawai, Jun Miyazaki, Hiroyuki Nishiyama

Open Access Invited Review Article

Recent progress and perspectives on prostate cancer biomarkers

Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Chikara Ohyama

Review Article

The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis

Xinshuai Wang, Xuezhen Ding, Dejiu Kong, Li Zhang, Yibo Guo, Jing Ren, Xiaochen Hu, Junqiang Yang, Shegan Gao

Original Article

Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution

Taichi Yoshida, Daiki Taguchi, Koji Fukuda, Kazuhiro Shimazu, Masahiro Inoue, Katsunori Murata, Hiroyuki Shibata

Original Article

Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer

Jun Sakakibara-Konishi, Yasuyuki Ikezawa, Satoshi Oizumi, Junko Kikuchi, Eiki Kikuchi, Hidenori Mizugaki, Ichiro Kinoshita, Hirotoshi Dosaka-Akita, Masaharu Nishimura

Original Article

Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis

Mei Feng, Jing Zhu, Liqun Liang, Ni Zeng, Yanqiu Wu, Chun Wan, Yongchun Shen, Fuqiang Wen

Original Article

A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer

Ying Liu, Ying Liao, Linlin Xiang, Kuo Jiang, Siyao Li, Mingmei Huangfu, Shilong Sun

Original Article

Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis

Harunobu Sato, Koutarou Maeda, Zenichi Morise, Hiroshi Takahashi, Kenichi Sugihara

Open Access Original Article

Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery

Hiroshi Miyakita, Sotaro Sadahiro, Gota Saito, Kazutake Okada, Akira Tanaka, Toshiyuki Suzuki

Original Article

Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems

Abdelfattah M. Attallah, Mohamed M. Omran, Ahmed A. Attallah, Mohamed A. Abdelrazek, Khaled Farid, Ibrahim El-Dosoky

Original Article

Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer

Ming Zhang, Na Li, Yannan Liang, Jinhui Liu, Yafeng Zhou, Chunying Liu

Original Article

Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study

Naoto Kamiya, Hiroyoshi Suzuki, Takahito Suyama, Masayuki Kobayashi, Satoshi Fukasawa, Nobuyuki Sekita, Kazuo Mikami, Naoki Nihei, Yukio Naya, Tomohiko Ichikawa

Original Article

Biphasic decline in renal function after radical cystectomy with urinary diversion

Katsuhiro Makino, Tohru Nakagawa, Atsushi Kanatani, Taketo Kawai, Satoru Taguchi, Masafumi Otsuka, Akihiko Matsumoto, Hideyo Miyazaki, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Yukio Homma

Original Article

Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma

Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

Original Article

Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients

Lisette Del Corso, Lucia Biale, Emanuele Luigi Parodi, Rodolfo Russo, Rosa Filiberti, Eleonora Arboscello

Original Article

Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study

Hiroki Hori, Tooru Kudoh, Shinichiro Nishimura, Megumi Oda, Makoto Yoshida, Junichi Hara, Akio Tawa, Ikuya Usami, Akihiko Tanizawa, Keiko Yumura-Yagi, Koji Kato, Ryoji Kobayashi, Yoshihiro Komada, Keitaro Matsuo, Keizo Horibe

Original Article

Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan

Kazuo Tamura, Keisuke Aiba, Toshiaki Saeki, Yoichi Nakanishi, Toshiharu Kamura, Hideo Baba, Kazuhiro Yoshida, Nobuyuki Yamamoto, Yuko Kitagawa, Yoshihiko Maehara, Mototsugu Shimokawa, Koichi Hirata, Masaki Kitajima

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.